Thursday, February 9, 2012

Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection

Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection
Ligand Pharmaceuticals Incorporated announced that it earned a US$ 6.5 million payment from Roche as a result of Roche progressing RG7348 into a phase-I clinical trial for the treatment of hepatitis C viral (HCV) infection.
Read more on [...]

Bristol-Myers Squibb Receives LEED® Silver Certification for its Biologics Manufacturing Facility in Devens …

Bristol-Myers Squibb Receives LEED® Silver Certification for its Biologics Manufacturing Facility in Devens …
DEVENS, Mass.—-Bristol-Myers Squibb Company announced today that it has received Leadership in Energy and Environmental Design Silver certification for its biologics manufacturing facility in Devens, Massachusetts.
Read more on Business Wire via Yahoo! Finance

Exactech Platform Fracture Stem for Shoulder Surgeries Receives FDA Clearance

Exactech Platform Fracture Stem for Shoulder Surgeries Receives FDA Clearance
GAINESVILLE, Fla.—-Exactech, Inc. , a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510 clearance from the U.S.
Read more on Business Wire via Yahoo! Finance

Powered by Yahoo! Answers